|
|||||
|
|
BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine. |
|
| Authors: | D Richman A S Rosenthal M Skoog R J Eckner T C Chou J P Sabo and V J Merluzzi |
| Institution: | University of California, San Diego 92161. |
| Abstract: | |
| Keywords: | |